[ad_1]
The company on Monday bumped its full-year sales forecast higher, and its second-quarter results beat expectations. Subscribers to its platform jumped 43% to 1.9 million.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...